Expression of Survivin Does Not Appear to Influence Breast Cancer Recurrence Risk

BACKGROUND: Survivin is an inhibitor of apoptosis, and its expression associates with poor outcomes in multiple cancers. It may be a therapeutic target due to its unique expression in cancer cells. METHODS: We estimated the association between nuclear and cytoplasmic survivin expression in primary t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Acta Oncol
Autors principals: Collin, Lindsay J, Cronin-Fenton, Deirdre P, Ahern, Thomas P, Christensen, Kristina B, Damkier, Per, Hamilton-Dutoit, Stephen, Kjærsgaard, Anders, Lauridsen, Kristina L, Yacoub, Rami, Christiansen, Peer, Sørensen, Henrik Toft, Lash, Timothy L
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6386593/
https://ncbi.nlm.nih.gov/pubmed/30351173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/0284186X.2018.1503419
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars